Ning Jiang, M.d./ph.d.

This study tests a shorter course of chemotherapy and radiation combined with the immunotherapy drug camrelizumab for people with advanced esophageal cancer that cannot be removed by surgery. About 98 participants will receive either the combination followed by maintenance immuno…